Pyrimidine compounds and methods using the same
US10961254B2 · kind B2 · utility
0Cited by
4References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 1, 2019 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Jul 1, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 2-amino-4-arylpyrimidine and 2-amino-4-aryltriazine compounds as inhibitors of heat shock protein 90 family of chaperone proteins. The invention also features pharmaceutical compositions and kits that include the compounds and compositions of the invention. The invention further relates to the medical use of these compounds and compositions for the treatment of a disorder in a subject. For example, the disorder is a neurodegenerative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.